PuSH - Publikationsserver des Helmholtz Zentrums München: Two-layered immune escape in AML is overcome by Fcγ receptor activation and inhibition of PGE2 signaling in NK cells.

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

EVA: Veröffentlichen

Neuer EVA Antrag

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Rothfuß, C.* ; Baumann, T.* ; Donakonda, S.* ; Brauchle, B.* ; Marcinek, A.* ; Urban, C.* ; Mergner, J.* ; Pedde, A.M.* ; Hirschberger, A.* ; Krupka, C.* ; Neumann, A.S.* ; Hänel, G.* ; Merten, C.* ; Öllinger, R.* ; Hecker, J.S.* ; Bauer, T. ; Schmid, C.R.* ; Götze, K.S.* ; Altomonte, J.* ; Bücklein, V.L.* ; Jacobs, R.* ; Rad, R.* ; Dawid, C.* ; Simeoni, L.* ; Schraven, B.* ; Pichlmair, A.* ; Subklewe, M.* ; Knolle, P.A.* ; Böttcher, J.P.* ; Höchst, B.*

Two-layered immune escape in AML is overcome by Fcγ receptor activation and inhibition of PGE2 signaling in NK cells.

Blood 145, 1395-1406 (2025)

Postprint

DOI

PMC

	Open Access Green

Abstract
Metriken
Zusatzinfos

Loss of anticancer NK cell function in AML patients is associated with fatal disease progression and remains poorly understood. Here, we demonstrate that AML-blasts isolated from patients rapidly inhibit NK cell function and escape NK cell-mediated killing. Transcriptome analysis of NK cells exposed to AML-blasts revealed increased CREM expression and transcriptional activity, indicating enhanced cAMP signalling, confirmed by uniform production of the cAMP-inducing prostanoid PGE2 by all AML-blast isolates from patients. Phosphoproteome analysis disclosed that PGE2 induced a blockade of LCK-ERK signalling that is crucial for NK cell activation, indicating a two-layered escape of AML-blasts with low expression of NK cell-activating ligands and inhibition of NK cell signalling. To evaluate the therapeutic potential to target PGE2 inhibition, we combined Fcg-receptor-mediated activation with the prevention of inhibitory PGE2-signalling. This rescued NK cell function and restored the killing of AML-blasts. Thus, we identify the PGE2-LCK signalling axis as the key barrier for NK cell activation in two-layered immune escape of AML-blasts that can be targeted for immune therapy to reconstitute anti-cancer NK cell immunity in AML patients.

Impact Factor

Scopus SNIP

Altmetric

23.100

0.000